– CANADA, Brossard – Diagnos Inc. (TSX: ADK | OTC: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence, today announced the appointment of Francis Bellido to its board of directors, effective November 27, 2019.
“We are pleased that Francis has accepted to join the Board. His great knowledge of the healthcare industry and his business relationships will directly contribute to the growth of our business,” said Mr. François Côté, Chairman of the Board.
About Francis Bellido
Mr. Bellido has spent his career overseeing and leading the development of several organizations in the healthcare industry. He brings sound financial management expertise, deep operating and leadership experience, and a global business perspective that he acquired over 30 years of international experience in the Biosciences, Healthcare and Financial industries. Notably, Mr. Bellido managed a CA$300M life science investment Fund that produced several key players in the Medical Device industry.
About Diagnos Inc.
Diagnos Inc. is a publicly-traded Canadian corporation with a mission of early detection of critical health issues through the use of its Artificial Intelligence tool CARA. CARA is a teleophthalmology platform that integrates with existing equipment and processes at the point of care. CARA’s Artificial Intelligence image enhancement algorithms make standard retinal images sharper, clearer and easier to read. CARA is accessible securely over the internet, and is compatible with all recognized image formats and brands of fundus cameras, and is EMR compatible. CARA is a cost-effective tool for screening large numbers of patients in real-time. CARA complies with local regulations, is FDA cleared for commercialization in the United States of America, is Health Canada licensed for commercialization in Canada and is CE marking compliant in Europe.
For more information: http://www.diagnos.ca
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
Comments are closed.